Annual report [Section 13 and 15(d), not S-K Item 405]

Financial Instruments - Summary Of Changes In Level One and Level Three Financial Assets (Details)

v3.26.1
Financial Instruments - Summary Of Changes In Level One and Level Three Financial Assets (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Loss on equity method investments $ (13) $ (211)
4 Front Venture Corp.    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 10 56
Additions 0 0
Revaluations (8) (46)
Loss on equity method investments 0 0
Ending balance 2 10
Other Long-term Investments [Member] | The Pharm Stand, LLC    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 125 0
Additions 0 125
Revaluations 0 0
Loss on equity method investments 0 0
Ending balance 125 125
Other Long-term Investments [Member] | Island Thyme LLC    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Beginning balance 728 679
Additions 0 260
Revaluations 0 0
Loss on equity method investments (13) (211)
Ending balance $ 715 $ 728